Zurcher Kantonalbank (Zurich Cantonalbank)

Bank

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1368163 ZURICH, V8

Back to AMLX Full portfolio

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$566,981

+$133,587 QoQ

Shares Held

40,790

+13.7% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Zurcher Kantonalbank (Zurich Cantonalbank) holds $112,181,802 across 35 Drug Manufacturers - Specialty & Generic names. AMLX ranks #18 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	54,824	$32,509,535
2	TEVA	Teva Pharmaceutical Industries Ltd	595,032	$17,922,363
3	ZTS	Zoetis Inc.	133,497	$15,780,680
4	NBIX	Neurocrine Biosciences Inc	94,379	$12,433,489
5	VTRS	Viatris Inc	627,641	$8,479,429
6	ELAN	Elanco Animal Health Inc	213,321	$5,104,771
7	ALKS	Alkermes plc.	66,815	$2,362,578
8	LNTH	Lantheus Holdings, Inc.	30,814	$2,337,241

All Filings in AMLX

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$566,981	40,790	+13.7%	Shares	Sole	2026-05-15
2025-12-31	$433,394	35,877	+1782.3%	Shares	Sole	2026-01-27
2025-09-30	$25,902	1,906	-32.5%	Shares	Sole	2025-11-14
2025-06-30	$18,095	2,823	-10.4%	Shares	Sole	2025-08-07
2025-03-31	$11,158	3,152	-68.5%	Shares	Sole	2025-05-07
2024-03-31	$28,462	10,022	-3.5%	Shares	Sole	2024-04-25
2023-12-31	$152,926	10,389	+69.4%	Shares	Sole	2024-01-30
2023-09-30	$112,313	6,134	+16.3%	Shares	Sole	2023-10-25
2023-06-30	$113,781	5,275	+667.8%	Shares	Sole	2023-08-07
2023-03-31	$20,156	687	—	Shares	Sole	2023-05-08
No filing history on record for this holder in this stock.